Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.44 |
| ▸ | CTSL | P07711 | 5/20 | 0.44 |
| ▸ | CDK1 | P06493 | 3/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30148786 | 0.91 | CTSL (0.44) | ADORA3ADORA1CTSLCDK1ADORA2A | |
| SCHEMBL30148823 | 0.91 | CTSL (0.45) | ADORA3ADORA1CTSLCDK1ADORA2A | |
| SCHEMBL30148811 | 0.89 | TDP1 (0.48) | CTSLCDK1TDP1CCNE1CDK2 | |
| SCHEMBL30148782 | 0.88 | YTHDC1 (0.58) | ADORA3ADORA1ADORA2A | |
| SCHEMBL30148802 | 0.82 | CTSL (0.46) | ADORA3ADORA1CTSLCDK1ADORA2A | |
| SCHEMBL30148780 | 0.81 | CDK1 (0.55) | CDK1TDP1CCNE1CDK2 | |
| SCHEMBL30148812 | 0.81 | CDK1 (0.45) | ADORA3ADORA1CDK1ADORA2ACCNE1 | |
| SCHEMBL30148779 | 0.80 | TDP1 (0.48) | CTSLCDK1TDP1CCNE1CDK2 | |
| SCHEMBL30148787 | 0.79 | YTHDC1 (0.59) | ADORA3ADORA1ADORA2A | |
| SCHEMBL30148797 | 0.79 | TDP1 (0.49) | CTSLCDK1TDP1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110903289-B | Purine-aminomethyl-pyridone derivative, preparation method and application thereof | 四川大学 | 2023-02-03 | — | — | CN | disclosed |